171 related articles for article (PubMed ID: 1356441)
1. In archaebacteria, there is a doxorubicin efflux pump similar to mammalian P-glycoprotein.
Miyauchi S; Komatsubara M; Kamo N
Biochim Biophys Acta; 1992 Oct; 1110(2):144-50. PubMed ID: 1356441
[TBL] [Abstract][Full Text] [Related]
2. Rhodamine 123 efflux transporter in Haloferax volcanii is induced when cultured under 'metabolic stress' by amino acids: the efflux system resembles that in a doxorubicin-resistant mutant.
Kaidoh K; Miyauchi S; Abe A; Tanabu S; Nara T; Kamo N
Biochem J; 1996 Feb; 314 ( Pt 1)(Pt 1):355-9. PubMed ID: 8660307
[TBL] [Abstract][Full Text] [Related]
3. A comparison of rhodamine 123 accumulation and efflux in cells with P-glycoprotein-mediated and MRP-associated multidrug resistance phenotypes.
Twentyman PR; Rhodes T; Rayner S
Eur J Cancer; 1994; 30A(9):1360-9. PubMed ID: 7999426
[TBL] [Abstract][Full Text] [Related]
4. Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells.
Anuchapreeda S; Leechanachai P; Smith MM; Ambudkar SV; Limtrakul PN
Biochem Pharmacol; 2002 Aug; 64(4):573-82. PubMed ID: 12167476
[TBL] [Abstract][Full Text] [Related]
5. Chemomodulation of drugs involved in multidrug resistance in chronic lymphatic leukemia of the B-cell type.
Reichle A; Diddens H; Altmayr F; Rastetter J; Andreesen R
Cancer Chemother Pharmacol; 1994; 34(4):307-16. PubMed ID: 7913420
[TBL] [Abstract][Full Text] [Related]
6. P-glycoprotein efflux pump expression and activity in Calu-3 cells.
Hamilton KO; Backstrom G; Yazdanian MA; Audus KL
J Pharm Sci; 2001 May; 90(5):647-58. PubMed ID: 11288109
[TBL] [Abstract][Full Text] [Related]
7. Functional characterization of a glycine 185-to-valine substitution in human P-glycoprotein by using a vaccinia-based transient expression system.
Ramachandra M; Ambudkar SV; Gottesman MM; Pastan I; Hrycyna CA
Mol Biol Cell; 1996 Oct; 7(10):1485-98. PubMed ID: 8898356
[TBL] [Abstract][Full Text] [Related]
8. Detection of activity of P-glycoprotein in human tumour samples using rhodamine 123.
Ludescher C; Thaler J; Drach D; Drach J; Spitaler M; Gattringer C; Huber H; Hofmann J
Br J Haematol; 1992 Sep; 82(1):161-8. PubMed ID: 1358171
[TBL] [Abstract][Full Text] [Related]
9. Early steps of the P-glycoprotein expression in cell cultures studied with vital fluorochrome.
Egudina SV; Stromskaya TP; Frolova EA; Stavrovskaya AA
FEBS Lett; 1993 Aug; 329(1-2):63-6. PubMed ID: 8102609
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of mdr1-dependent transport activity delay accumulation of the mdr1 substrate rhodamine 123 in primary rat hepatocyte cultures.
Hirsch-Ernst KI; Ziemann C; Rustenbeck I; Kahl GF
Toxicology; 2001 Oct; 167(1):47-57. PubMed ID: 11557129
[TBL] [Abstract][Full Text] [Related]
11. Characterization of rhodamine 123 binding to P-glycoprotein in human multidrug-resistant cells.
Nare B; Prichard RK; Georges E
Mol Pharmacol; 1994 Jun; 45(6):1145-52. PubMed ID: 7912815
[TBL] [Abstract][Full Text] [Related]
12. Relationships between rhodamine 123 transport, cell volume, and ion-channel function of P-glycoprotein.
Altenberg GA; Vanoye CG; Han ES; Deitmer JW; Reuss L
J Biol Chem; 1994 Mar; 269(10):7145-9. PubMed ID: 7510282
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric analysis of P-glycoprotein function using rhodamine 123.
Pétriz J; García-López J
Leukemia; 1997 Jul; 11(7):1124-30. PubMed ID: 9205001
[TBL] [Abstract][Full Text] [Related]
14. Preferential expression and activity of multidrug resistance gene 1 product (P-glycoprotein), a functionally active efflux pump, in human CD8+ T cells: a role in cytotoxic effector function.
Gupta S; Kim CH; Tsuruo T; Gollapudi S
J Clin Immunol; 1992 Nov; 12(6):451-8. PubMed ID: 1363104
[TBL] [Abstract][Full Text] [Related]
15. Verapamil decreases P-glycoprotein expression in multidrug-resistant human leukemic cell lines.
Muller C; Bailly JD; Goubin F; Laredo J; Jaffrézou JP; Bordier C; Laurent G
Int J Cancer; 1994 Mar; 56(5):749-54. PubMed ID: 7906257
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometric functional analysis of multidrug resistance by Fluo-3: a comparison with rhodamine-123.
Koizumi S; Konishi M; Ichihara T; Wada H; Matsukawa H; Goi K; Mizutani S
Eur J Cancer; 1995 Sep; 31A(10):1682-8. PubMed ID: 7488425
[TBL] [Abstract][Full Text] [Related]
17. A low but functionally significant MDR1 expression protects primitive haemopoietic progenitor cells from anthracycline toxicity.
Smeets M; Raymakers R; Vierwinden G; Pennings A; van de Locht L; Wessels H; Boezeman J; de Witte T
Br J Haematol; 1997 Feb; 96(2):346-55. PubMed ID: 9029024
[TBL] [Abstract][Full Text] [Related]
18. Unidirectional fluxes of rhodamine 123 in multidrug-resistant cells: evidence against direct drug extrusion from the plasma membrane.
Altenberg GA; Vanoye CG; Horton JK; Reuss L
Proc Natl Acad Sci U S A; 1994 May; 91(11):4654-7. PubMed ID: 7910961
[TBL] [Abstract][Full Text] [Related]
19. The role of passive transbilayer drug movement in multidrug resistance and its modulation.
Eytan GD; Regev R; Oren G; Assaraf YG
J Biol Chem; 1996 May; 271(22):12897-902. PubMed ID: 8662680
[TBL] [Abstract][Full Text] [Related]
20. Comparison between anthracyclines and rhodamine-123 accumulation in chronic lymphoid leukemia: effect of cyclosporin A and verapamil.
Maia RC; Vasconcelos FC; Harab RC; Coelho AM; Dobbin JA; Rumjanek VM
Tumour Biol; 1998; 19(1):41-51. PubMed ID: 9422081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]